German Pharma Companies Are Meeting the Corona "Stress Test"

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

German Pharma Companies Are Meeting the Corona "Stress Test"

The head of the leading German pharmaceutical industry organization says German firms are working top-speed to find coronavirus medications

Canada NewsWire

BERLIN, April 6, 2020 /CNW/ -- Amidst the coronavirus pandemic people in many countries worry whether too many crucial elements in their healthcare systems have been outsourced, in particular to China. But that's not a concern for German pharma, says Han Steutel, the president of the German Association of Research-Based Pharmaceutical Companies (VfA).

"Germany is one of the world's strongest production locations where innovative, patented medications are concerned," Steutel explained. "Even amidst the stress test of the corona pandemic, Germany has remained capable of delivering and has exported significantly more patented medical products to China than it has imported from that country."

Death rates from Sars-CoV-2, the respiratory disease caused by the coronavirus, are far lower in Germany than almost everywhere else in the world. The VfA says German expertise is hard at work in all areas of the fight against corona-related ailments.

"There are around 60 companies and institutes working at top speed on vaccines," says Steutel. "Several dozens of existing medications are being tested to see if they can help corona patients. And a series of new medications are being developed, mostly on the basis of antibodies. German companies and institutes are part of all three efforts."

Steutel added that Germany's 44 researched-based pharmaceutical companies were cooperating internationally and with biotech firms in the search for corona medications.

The full interview with Han Steutel is available here: https://www.marketsgermany.com/german-pharma-and-the-corona-crisis/

Germany Trade & Invest (GTAI) is the economic development agency of the Federal Republic of Germany. GTAI supports German companies setting up in foreign markets, promotes Germany as a business location and assists foreign companies setting up in Germany.

Contact:
Jefferson Chase
Senior Manager, Communications
Germany Trade & Invest
Friedrichstraße 60
10117 Berlin
+49-302-0009-9170
[email protected]

www.gtai.com

Cision View original content:http://www.prnewswire.com/news-releases/german-pharma-companies-are-meeting-the-corona-stress-test-301035956.html

SOURCE Germany Trade & Invest

Cision View original content: http://www.newswire.ca/en/releases/archive/April2020/06/c8734.html

Copyright CNW Group 2020

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).